The contents of the electronic sequence listing (CU761SequenceListing.xml; Size: 20,505 bytes; and Date of Creation: Aug. 11, 2023) is herein incorporated by reference in its entirety.
The disclosure belongs to the technical field of biotechnology and genetic breeding, particularly to a method for overcoming self-incompatibility of diploid potatoes.
A diploid potato belongs to gametophytic self-incompatibility type, and its pollen tubes can germinate on the stigma and elongate into the style, but the growth is subsequently inhibited. This trait is controlled by the S-RNase gene, and the expression of this gene inhibits the elongation of the pollen tubes, making it difficult for the potatoes to obtain an inbred plant line.
Previous studies have found that a tobacco S-RNase gene is only slightly expressed during the period from flower bud to bud stage, while higher S-RNase protein enrichment is detected in flowering stage. Our research on potato pistil proteins has also reaches the similar conclusion, and this creates the possibility of overcoming self-incompatibility of potatoes through self-crossing at the bud stage. However, self-crossing at the bud stage has higher requirements for pollination times and environment, lower fruit setting rate and fewer seeds, and the plants growing from the seeds of the self-crossing are still self-incompatible plants. The method is time-consuming and laborious, and the cost is extremely high; the self-compatibility is only exhibited in the generation for self-crossing at the bud stage, and is not heritable. The method of self-crossing at the bud stage cannot achieve the creation of self-compatible materials.
In 1998, Hosaka and Hanneman mapped a Sli (S-locus inhibitor) gene locus derived from the wild species S. chacoense, this gene confers self-compatibility to diploid potatoes. However, the infiltration of the Sli gene into a cultivar potato will inevitably bring in unfavorable traits, such as longer stolons, smaller potato tubers, and increased steroidal glycosides and alkaloids.
Therefore, it is desirable to create self-compatible potato materials in a better way. At present, no research institution has made breakthroughs in this regard.
In order to solve the problem that there is no better method to create a self-compatible potato material in the prior art, the disclosure provides a method for overcoming self-incompatibility of diploid potatoes. The purpose of the disclosure is to find a simple, accurate and efficient method to overcome self-incompatibility of diploid potatoes, i.e., overcoming the self-incompatibility barrier of diploid potatoes, thereby providing core technology support for the creation of a self-compatible material and a homozygous inbred plant line.
In order to achieve the above object, the disclosure provides the following technical solutions. The disclosure provides a method for overcoming self-incompatibility of diploid potatoes, which comprises the following steps:
The gene regions of Sp3 and Sp4 in the S-RNase gene as a potato self-incompatibility determining gene comprise an exon and a promoter, or a portion thereof.
Further, in the step (1) the target fragment is located on the target gene S-RNase, and one strand of the target fragment has the nucleic acid sequence structure as shown in SEQ ID No:1. For example, wherein the target fragment is located on the target S-RNase gene, one strand of the target fragment has a 5′-(N)X-NGG-3′ structure, and (N)X represents a base sequence having the base number of X {N1, N2, . . . , NX}, and each of N1, N2, . . . NX represents any one of bases A, G, C, and T, and N in NGG is any one of A, G, C, and T. X is an integer from 15 to 25, preferably, said X is an integer from 17 to 23; more preferably, said X is 18, 19, 20, or 21.
Further, in the step (2) the recombinant vector comprises the target fragment, wherein the target fragment is the nucleic acid sequence of SEQ ID No:1 or a sequence complementary thereof.
Another aspect of the disclosure provides a potato plant, and a plant part, a tuber or tuber part, a plant cell, a pollen or a seed thereof, it comprises a loss-of-function mutation of the S-RNase gene, wherein the nucleotide sequence of the S-RNase gene is the sequence shown in SEQ ID NO:2 (Sp3), or a complementary sequence, a degenerate sequence, or a homologous sequence thereof; and/or the sequence shown in SEQ ID NO:3 (Sp4), or a complement sequence, a degenerate sequence, or a homologous sequence thereof.
In a particular embodiment of the disclosure, the homologous sequence of the nucleotide sequence of the S-RNase protein may be a polynucleotide hybridizing with a nucleotide sequence in SEQ ID NO:2 and/or SEQ ID NO:3 or a complementary sequence thereof under stringent conditions, or a fragment of the polynucleotide, wherein such a polynucleotide or a fragment thereof does not express the S-RNase protein.
The “stringent conditions” described herein may be any kind of the followings: low stringency conditions, medium stringency conditions, and high stringency conditions, preferably high stringency conditions. Exemplarily, the “low stringency conditions” may be the conditions of 30° C., 5×SSC, 5×Denhardts solution, 0.5% SDS, 52% formamide; “medium stringent conditions” may be the conditions of 40° C., 5×SSC, 5×Denhardts solution, 0.5% SDS, 52% formamide; “high stringency conditions” may be the conditions of 50° C., 5×SSC, 5×Denhardts solution, 0.5% SDS, 52% formamide. Those skilled in the art will appreciate that the higher the temperature, the more highly homologous polynucleotides can be obtained. In addition, one skilled in the art can select a comprehensive result produced by a plurality of factors affecting the stringency of hybridization such as the temperature, probe concentration, probe length, ionic strength, time, and salt concentration, etc. so as to achieve a corresponding stringency.
In addition, the hybridizable polynucleotide may be such a polynucleotide, when calculated by a homology search software such as FASTA or BLAST with default parameters set by the system, the polynucleotide has about 30% or more, 40% or more, 50 or more, 60% or more, about 70% or more, 71% or more, 72% or more, 73% or more, 74% or more, 75% or more, 76% or more, 77% or more, 78% or more, 79% or more, 80% or more, 81% or more, 82% or more, 83% or more, 84% or more, 85% or more, 86% or more, 87% or more, 88% or more, 89% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, 99.1% or more, 99.2% or more, 99.3% or more, 99.4% or more, 99.5% or more, 99.6% or more, 99.7% or more, 99.8% or more, or 99.9% or more homology with the polynucleotide according to the disclosure.
For homology of nucleotide sequences, it may be determined by the BLAST algorithmic rules of Karlin and Altschul (Proc. Natl. Acad. Sci. USA 87: 2264-2268, 1990; Proc. Natl. Acad. Sci. USA 90: 5873, 1993). The programs based on the BLAST algorithmic rules such as BLASTN and BLASTX have been developed (Altschul SF, et al: J Mol Biol 215: 403, 1990). When analyzing the base sequence by using BLASTN, for example, the parameters are: score=100, wordlength=12; when using the BLAST and Gapped BLAST programs, the default parameter values may be set in the system using each of the programs.
In a particular embodiment of the disclosure, the loss-of-function of the S-RNase gene is achieved by addition and/or deletion of (one or more) nucleotides in the gene expressing the S-RNase protein. For example, the addition of one, two or more nucleotides; or the deletion of one, two or more nucleotides; or the replacement of one, two or more nucleotides in the gene expressing the S-RNase protein.
Exemplarily, the nucleotide sequence of the S-RNase protein is the sequence shown in SEQ ID NO:2 (Sp3), or a complementary sequence, a degenerate sequence, or a homologous sequence thereof; and/or the sequence shown in SEQ ID NO:3 (Sp4), or a complement sequence, a degenerate sequence, or a homologous sequence thereof.
In a particular embodiment of the disclosure, the loss of function of the S-RNase gene is achieved by addition, deletion or replacement of (one or more) nucleotides in the sequence of ACGATTCACGGGCTTTGGCC (i.e., SEQ ID No:10) or a complementary sequence thereof. For example, the addition of 1 to 5 nucleotides, deletion of 1 to 10 nucleotides, or replacement of 1 to 8 nucleotides, etc.
In a particular embodiment of the disclosure, the addition, deletion or replacement of nucleotides is achieved by a CRISPR/Cas9 recombinant vector.
In a particular embodiment of the disclosure, the CRISPR/Cas9 recombinant vector is capable of targeting the gene of the S-RNase protein, wherein the nucleotide sequence of the S-RNase protein is the sequence shown in SEQ ID NO:2 (Sp3), or a complementary sequence, a degenerate sequence, or a homologous sequence thereof; and/or the sequence shown in SEQ ID NO:3 (Sp4), or a complement sequence, a degenerate sequence, or a homologous sequence thereof.
In a particular embodiment of the disclosure, the CRISPR/Cas9 recombinant vector is capable of targeting the first exon region of the S-RNase gene.
In a particular embodiment of the disclosure, the CRISPR/Cas9 recombinant vector is capable of targeting the sequence of ACGATTCACGGGCTTTTGGCCGG (i.e., SEQ ID No:11) in the S-RNase gene or a complementary sequence thereof.
In a particular embodiment of the disclosure, the nucleotide sequence of the sgRNA in the CRISPR/Cas9 recombinant vector is:
xxxxACGATTCACGGGCTTTGGC,
xxxxGCCAAAGCCCGTGAATCGT;
wherein the portion not underlined is a sequence in above target site with deletion of NGG or a complementary sequence thereof, and the underlined portion is a cohesive end for ligation of the vector.
In another aspect, the disclosure provides a CRISPR/Cas9 recombinant vector for targeted knockout of S-RNase gene, the nucleotide sequence of the S-RNase gene targeted by the CRISPR/Cas9 recombinant vector is the sequence shown in SEQ ID NO:2 (Sp3), or a complementary sequence, a degenerate sequence, or a homologous sequence thereof; and/or the sequence shown in SEQ ID NO:3 (Sp4), or a complement sequence, a degenerate sequence, or a homologous sequence thereof.
In a particular embodiment of the disclosure, the CRISPR/Cas9 recombinant vector is capable of targeting the first exon region of the S-RNase gene.
In a particular embodiment of the disclosure, the CRISPR/Cas9 recombinant vector is capable of targeting the sequence of ACGATTCACGGGCTTTTGGCCGG (i.e., SEQ ID No:11) in the S-RNase gene or a complementary sequence thereof.
In a particular embodiment of the disclosure, the nucleotide sequence of the sgRNA in the CRISPR/Cas9 recombinant vector is:
xxxxACGATTCACGGGCTTTGGC,
xxxxGCCAAAGCCCGTGAATCGT;
wherein the portion not underlined is a sequence in above target site with deletion of NGG or a complementary sequence thereof, and the underlined portion is a cohesive end for ligation of the vector.
In a particular embodiment of the disclosure, the construction of the CRISPR/Cas9 recombinant vector comprises the following steps:
Exemplarily, the sequences of the primers S-RNase P3 and S-RNase P4 are as follows:
xxxxACGATTCACGGGCTTTGGC,
xxxxGCCAAAGCCCGTGAATCGT;
wherein the portion not underlined is a sequence in above target site with deletion of NGG or a complementary sequence thereof, and the underlined portion is a cohesive end for ligation of the vector.
Another aspect of the disclosure provides use of the above CRISPR/Cas9 recombinant vector in the preparation of knockout of S-RNase protein gene.
Another aspect of the disclosure provides a method for breeding a self-compatible potato, which comprises the step of making the S-RNase gene in a potato unexpressed or inactivated, wherein the S-RNase gene is the sequence shown in SEQ ID NO:2 (Sp3), or a complementary sequence, a degenerate sequence, or a homologous sequence thereof; and/or the sequence shown in SEQ ID NO:3 (Sp4), or a complement sequence, a degenerate sequence, or a homologous sequence thereof.
In a particular embodiment of the disclosure, the breeding method specifically includes:
Another aspect of the disclosure provides a method for breeding a potato, which comprises utilizing the potato plant, and a plant part, a tuber or tuber part, a plant cell, a pollen or a seed thereof described above, or the potato plant obtained by the above breeding method to perform self-crossing.
Another aspect of the disclosure provides a method for manufacturing a commercial plant product, which comprises: obtaining the plant or a plant part thereof described above and manufacturing the commercial plant product from the plant or a plant part thereof, wherein the plant products are selected from the group consisting of: fresh whole potatoes, French fries, potato chips, dehydrated potato materials, potato flakes, and potato granules.
Another aspect of the disclosure provides a food product made from a potato plant, a tuber, or a tuber part growing from the potato plant, and a plant part, a tuber or tuber part, a plant cell, a pollen or a seed thereof described above.
In a particular embodiment of the disclosure, the food product is a sliced potato tuber food.
In a particular embodiment of the disclosure, the food product is a group consisting of French fries, potato chips and baked potatoes.
The disclosure adopts the above technical solutions, and it brings the following beneficial effects. Compared with the conventional methods for solving the self-incompatibility of potatoes, the disclosure has the following advantages:
The disclosure will be further described in detail below with reference to a particular example and the drawings.
Example 1: The disclosure provides a method for overcoming the self-incompatibility of diploid potatoes, which comprises the following steps:
The specific operations are as follows:
The specific sequences are as follows:
xxxxACGATTCACGGGCTTTGGC,
xxxxGCCAAAGCCCGTGAATCGT;
The specific operations for detecting the gene editing of the potato S-RNase in the above steps:
It can be seen from
aThe number before the slash represents the number of individual plants without Cas9 in the detected T1 generation, the number after the slash represents the number of individual plants in the detected T1 generation;
bthe isolation of S-RNase type for the individual plants without Cas9 in the T1 generation;
cindicates the S-RNase mutation type.
The medium formulations used above are shown in the following tables:
The above description is only the preferred example of the disclosure, and is not intended to limit the disclosure. For those skilled in the art, various modifications and changes can be made to the disclosure. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and the scope of the disclosure should be included in the scope of the disclosure.
Number | Date | Country | Kind |
---|---|---|---|
201810308517.5 | Apr 2018 | CN | national |
201910108556.5 | Jan 2019 | CN | national |
This application is a continuation of U.S. application Ser. No. 16/960,292, filed on Jul. 6, 2020, which is a 371 of PCT/CN2019/081515, filed on Apr. 4, 2019. The International Application claims priority to Chinese Patent Application No. CN201810308517.5, filed on Apr. 8, 2018 and Chinese Patent Application No. CN201910108556.5, filed on Jan. 18, 2019. All of the afore-mentioned patent applications are hereby incorporated by reference in their entireties.
Number | Date | Country | |
---|---|---|---|
Parent | 16960292 | Jul 2020 | US |
Child | 18448621 | US |